Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine

Cardiovascular Research

Volumn 67, Issue 1, 2005, Pages 124-133

  Kin, Hajime ^a   Zatta, Amanda J ^a   Lofye, Mark T ^a   Amerson, Bradley S ^a   Halkos, Michael E ^a   Kerendi, Faraz ^a   Zhao, Zhi Qing ^a   Guyton, Robert A ^a   Headrick, John P ^b   Vinten Johansen, Jakob ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Adenosine; Infarction; Postconditioning; Receptors; Reperfusion

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; DIMETHYL SULFOXIDE; PURINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MODEL; HEART CONTRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHESIS; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RANDOMIZATION; RAT; THORAX; TIME;

ADENOSINE; ANIMALS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; PERFUSION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; TRIAZINES; TRIAZOLES; XANTHINES;

EID: 20444402649     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.02.015     Document Type: Article

References (51)

1. H.M. Piper, D. Garcia-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300
2. J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res 61 2004 481 497
3. J. Vinten-Johansen, D.J. Lefer, K. Nakanishi, W.E. Johnston, C.A. Brian, and A.R. Cordell Controlled coronary hydrodynamics at the time of reperfusion reduces postischemic injury Coron Artery Dis 1992 1081 1093
4. H. Sato, J.E. Jordan, Z.-Q. Zhao, S.S. Sarvotham, and J. Vinten-Johansen Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation Ann Thorac Surg 64 1997 1099 1107
5. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
6. H. Kin, Z.Q. Zhao, H.Y. Sun, N.P. Wang, J.S. Corvera, and M.E. Halkos Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion Cardiovasc Res 62 2004 74 85
7. M.E. Halkos, F. Kerendi, J.S. Corvera, N.P. Wang, H. Kin, and C.S. Payne Myocardial protection with postconditioning is not enhanced by ischemic preconditioning Ann Thorac Surg 78 2004 961 969
8. H.Y. Sun, N.P. Wang, F. Kerendi, M. Halkos, H. Kin, and R.A. Guyton Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting the generation of reactive oxygen species and intracellular calcium overload Am J Physiol Heart Circ Physiol 2004 [Electronic publication ahead of print]
9. X.M. Yang, J.B. Proctor, L. Cui, T. Krieg, J.M. Downey, and M.V. Cohen Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways J Am Coll Cardiol 44 2004 1103 1110
10. A. Tsang, D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway Circ Res 95 2004 230 232
11. R.D. Lasley, and R.M. Mentzer Jr. Protective effects of adenosine in the reversibly injured heart Ann Thorac Surg 60 1995 843 846
12. J. Vinten-Johansen, V.H. Thourani, R.S. Ronson, J.E. Jordan, Z.Q. Zhao, and M. Nakamura Broad-spectrum cardioprotection with adenosine Ann Thorac Surg 68 1999 1942 1948
13. J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection Annu Rev Pharmacol Toxicol 41 2001 775 787
14. J.P. Headrick, B. Hack, and K.J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol 285 2003 H1797 H1818
15. Z.-Q. Zhao, D.S. McGee, K. Nakanishi, C.F. Toombs, W.E. Johnston, and M.S. Ashar Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit Circulation 88 1993 709 719
16. G.F. Baxter, S.L. Hale, T. Miki, R.A. Kloner, M.V. Cohen, and J.M. Downey Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study Cardiovasc Drugs Ther 14 2000 607 614
17. 1 receptor stimulation during reperfusion following ischaemia Br J Pharmacol 118 1996 355 363
18. 1 adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts Am J Physiol Heart Circ Physiol 279 2000 H2166 H2175
19. 1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia Cardiovasc Res 28 1994 270 279
20. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence J Pharmacol Exp Ther 280 1997 301 309
21. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury Am J Physiol Heart Circ Physiol 277 1999 H1895 H1905
22. 2A agonist CGS-21680 in infarcted and stunned porcine myocardium Am J Physiol Heart Circ Physiol 280 2001 H1660 H1666
23. Z.Q. Zhao, J.M. Budde, C. Morris, N.P. Wang, D.A. Velez, and S. Muraki Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins J Mol Cell Cardiol 33 2001 57 68
24. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury Am J Physiol Heart Circ Physiol 283 2002 H1307 H1313
25. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs Am J Physiol Heart Circ Physiol 285 2003 H607 H613
26. 2A receptor and Erk1/2 Cardiovasc Drugs Ther 17 2003 415 425
27. 2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway J Cardiovasc Pharmacol 43 2004 416 422
28. A.J. Flood, L. Willems, and J.P. Headrick Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart Cardiovasc Res 55 2002 161 170
29. J. Peart, A.J. Flood, J. Linden, G.P. Matherne, and J.P. Headrick Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart J Cardiovasc Pharmacol 39 2002 117 129
30. 2A selective adenosine receptor antagonist Br J Pharmacol 115 1995 1096 1102
31. 2A receptor antagonist Eur J Pharmacol 301 1996 107 113
32. 3 adenosine receptor antagonists J Med Chem 41 1998 3186 3201
33. J.N. Peart, and G.J. Gross Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors Am J Physiol Heart Circ Physiol 285 2003 H81 H89
34. M.V. Cohen, G.S. Liu, and J.M. Downey Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits Circulation 84 1991 341 349
35. R.D. Lasley, and R.M. Mentzer Jr. Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism Am J Physiol Heart Circ Physiol 263 1992 H1460 H1465
36. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart Cardiovasc Res 33 1997 410 415
37. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart J Mol Cell Cardiol 30 1998 579 585
38. 3 receptors Cardiovasc Res 51 2001 701 708
39. J. Peart, L. Willems, and J.P. Headrick Receptor and non-receptor- dependent mechanisms of cardioprotection with adenosine Am J Physiol Heart Circ Physiol 284 2003 H519 H527
40. 3 receptors reduce ischemic myocardial injury Am J Physiol Heart Circ Physiol 285 2003 H2780 H2787
41. 2 receptors J Cardiovasc Pharmacol 38 2001 474 481
42. G.J. Harrison, R.J. Willis, and J.P. Headrick Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart Cardiovasc Res 40 1998 74 87
43. C.E. Ganote, and S.C. Armstrong Adenosine and preconditioning in the rat heart Cardiovasc Res 45 2000 134 140
44. R.D. Lasley, J.O. Hegge, M.A. Noble, and R.M. Mentzer Jr. Comparison of interstitial fluid and coronary venous adenosine levels in in vivo porcine myocardium J Mol Cell Cardiol 30 1998 1137 1147
45. B.N. Cronstein Adenosine, an endogenous anti-inflammatory agent J Appl Physiol 76 1994 5 13
46. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium Am J Physiol Heart Circ Physiol 271 2004 H1456 H1464
47. 2 receptor on human neutrophils J Immunol 135 1985 1366 1371
48. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis Mol Pharmacol 59 2001 76 82
49. Q. Qin, J.M. Downey, and M.V. Cohen Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase Am J Physiol Heart Circ Physiol 284 2003 H727 H734
50. 1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity Am J Physiol Heart Circ Physiol 284 2003 H859 H866
51. X.M. Yang, S. Philipp, J.M. Downey, and M.V. Cohen Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation Basic Res Cardiol 100 2005 57 63